Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-27 @ 8:26 AM
Study NCT ID:
NCT03485950
Status:
COMPLETED
Last Update Posted:
2022-03-15
First Post:
2018-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-26
First Submit QC Date:
None
Study First Post Date:
2018-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-02
Results First Submit QC Date:
None
Results First Post Date:
2021-07-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-04
Last Update Post Date:
2022-03-15
Last Update Post Date Type:
ACTUAL